DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ST ...
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in acute care therapies, announced today the commercial launch of a new indication for the company’s oXiris set, which ...
Baxter International Inc. BAX recently announced the global launch of the latest version of its next-generation platform, PrisMax 2. The PrisMax 2 system aims to help streamline the delivery of ...
In comparison to the flood of emergency use authorizations doled out by the FDA throughout the COVID-19 pandemic, the number of those tests and devices that have gone on to receive full, non-pandemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results